Clinical Trial Update: OK432 (Picibanil) in the Treatment of Lymphatic Malformations [Phase 2]

View source ↗

Summary

Phase 2 trial update on OK432 (Picibanil) for lymphatic malformations with completed status and posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lymphatic Malformations

Drugs mentioned

• OK432 (Picibanil) (OK432 (Picibanil))

Snippet

Sponsor: Richard JH Smith | Conditions: Lymphatic Malformations | Phase 2 | Status: COMPLETED | Results posted: 2021-10-28